Chris A. Rallis - May 19, 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A Rallis
Stock symbol
FENC
Transactions as of
May 19, 2023
Transactions value $
-$12,939
Form type
4
Date filed
5/19/2023, 04:41 PM
Previous filing
Apr 17, 2023
Next filing
Jun 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Sale -$6.13K -833 -2.54% $7.36 32K May 19, 2023 Direct F1
transaction FENC Common Shares Sale -$6.81K -925 -2.89% $7.36 31K May 19, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 4/4/2012.
F2 Sale of common shares sold in accordance with 10b5-1 plan. Commom shares resulted from exercise of option grant with grant date of 5/17/2012.